Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI AB annual general meeting moved to 27 October 2023
The PHI AB board has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023.
Learn more …
PostNews
BioStock: PHI links up with two regenerative medicine networks
BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.
Learn more …
PostNews: Press Release
PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership
PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
Learn more …
PostNews
BioStock: PHI charts a bold course to impact regenerative medicine
BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
Learn more …
PostNews
BioStock: The five best life science stocks of the first half-year
PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
Learn more …
PostNews: Press Release
European Patent Office intends to grant PHI patent on synthetic antibodies
PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
Learn more …